Insulet has launched the Omnipod 5 automated insulin delivery app for iPhone in the US. The app obviates the need for ...

Omnipod 5, performed better than conventional insulin pumps in a clinical trial for patients with type 1 diabetes. Its OP5-003 trial, conducted in the U.S. and France for adults with type 1 ...

Modern insulin pumps are self-contained devices that attach ... Curious as to what was inside, [Ido Roseman] tore down an Omnipod Dash and took some pictures showing what was inside.

Insulet raised its annual revenue growth forecast on Thursday, banking on strong demand for its wearable insulin pumps.

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

Insulet's Omnipod The deal has been axed a few weeks after a federal judge in the US blocked EOFlow from selling its insulin patch pump in a lawsuit brought by Insulet, which sells a rival product.

Analyst Jeff Johnson from Robert W. Baird maintained a Buy rating on Insulet (PODD – Research Report) and keeping the price target at ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its ...

Insulet (Nasdaq:PODD) today announced its plans to recognize National Diabetes Awareness Month and World Diabetes Day.

Insulet ( (PODD) ) has released its Q3 earnings. Here is a breakdown of the information Insulet presented to its investors. Insulet ...

The insulin pump market is projected to reach $14bn in the same period, as per GlobalData analysis. Insulet also secured label expansion for Omnipod 5 device from the FDA allowing for its use in ...